Washington University School of Medicine led a study evaluating long-term gantenerumab treatment in individuals with ...

Limp Bizkit’s $200 million lawsuit against Universal Music will head to trial after a federal judge denied the label’s motion ...

Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be ...

A significant benefit was observed with Tysabri over Rebif in delaying SPMS disability progression when therapeutic lag was ...

Angel Del Villar is expected to face testimony from his former label star Gerardo Ortiz, who prosecutors say took a plea deal ...

Off-label prescribing has entered standard treatments and is at the cutting edge of medical innovation, but it carries ...

The entertainment news features NewJeans' legal battle with their label in South Korea, Gerard Depardieu's upcoming trial ...

Topline data expected as early as mid-2025 - SOUTH SAN FRANCISCO, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the initiation of a Phase 1, open label, dose ...

Mase announces triple album release on May 5 coinciding with Diddy's trial, collaborating with Cam'ron in what appears to be ...

The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products based on ...

An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in ...

Long-term removal of amyloid beta in people genetically destined to develop Alzheimer's disease may have delayed symptoms and ...